Why the study?
Does levosimendan improve outcomes in various acute heart failure settings?
Does levosimendan improve outcomes in various acute heart failure settings?
Levosimendan is a versatile inodilator with potential applications in various acute heart failure settings, though full confirmation of its effectiveness in many scenarios is still awaited.
No takes yet. Share an insight, caveat, or question.
May benefit acute HF with ACS or shock; leaves open role pending randomized data.
Gustafsson et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: